Singapore markets closed

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5540+0.0740 (+5.00%)
As of 01:57PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.33-0.31-1.23-1.01
Low estimate-0.37-0.34-1.33-1.27
High estimate-0.28-0.27-1.09-0.77
Year ago EPS-0.3-0.29-1.25-1.23
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate34.47M36.42M146.52M164.74M
Low estimate31.7M34.6M142.44M130.2M
High estimate38.36M39.4M150.84M209.72M
Year ago sales36.6M37.58M146.03M146.52M
Sales growth (year/est)-5.80%-3.10%0.30%12.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.37-0.34-0.28-0.31
Actual EPS-0.3-0.29-0.3-0.36
Difference0.070.05-0.02-0.05
Surprise %18.90%14.70%-7.10%-16.10%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.33-0.31-1.23-1.01
7 days ago-0.33-0.31-1.23-1.01
30 days ago-0.31-0.31-1.15-1.04
60 days ago-0.3-0.29-1.09-0.96
90 days ago-0.2-0.22-0.86-0.74
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1113
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKPTIIndustrySector(s)S&P 500
Current qtr.-10.00%N/AN/AN/A
Next qtr.-6.90%N/AN/AN/A
Current year1.60%N/AN/AN/A
Next year17.90%N/AN/AN/A
Next 5 years (per annum)-30.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A